GSK PLC GLAXF
FOREIGN · Common Stock · CUSIP G3910J179
British multinational pharmaceutical and biotechnology company
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $26.29.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 1 |
| Q1 2023 | 1 |
| Q2 2023 | 2 |
| Q3 2023 | 2 |
| Q4 2023 | 2 |
| Q1 2024 | 2 |
| Q2 2024 | 2 |
| Q3 2024 | 2 |
| Q4 2024 | 2 |
| Q1 2025 | 1 |
| Q2 2025 | 1 |
| Q3 2025 | 2 |
| Q4 2025 | 1 |
| Q1 2026 | 2 |
| Q2 2026 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 2 | 1 |
| Q4 2024 | 1 | 2 |
| Q1 2025 | 0 | 2 |
| Q2 2025 | 1 | 0 |
| Q3 2025 | 1 | 1 |
| Q4 2025 | 0 | 2 |
| Q1 2026 | 1 | 1 |
| Q2 2026 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| Aristotle Capital Management, LLC | Reduced | -190.8k |
| Generali Investments CEE, investicni spolecnost, a.s. | Reduced | -4.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BlackRock, Inc. 13G · institution filed 2025-03-07 | 8.9% |
| FMR LLC 13G · institution new · filed 2026-05-06 | 5.8% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Aristotle Capital Management, LLC 0.15% of their portfolio | 2.6m $69.3m | Reduced -190.8k |
| Generali Investments CEE, investicni spolecnost, a.s. 0.04% of their portfolio | 34.1k $895.8k | Reduced -4.2k |